One researcher’s development of a swallowable, diagnostic capsule underscores the progress and promise of the MGH Research Scholars program.
Mass General President Peter L. Slavin, MD, says the hospital’s scientists and clinicians work together to ensure that research informs care and vice versa.
With key support from Colleen’s Dream Foundation, Mass General researcher Cheng Wang, PhD, aims to improve the chances of early detection and treatment of ovarian cancer.
A clinician-investigator from Mass General’s Multiple Sclerosis Clinic discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.
Scientists representing the Mass General Research Institute participated in the recent Cambridge Science Festival as part of an effort to make science more accessible, interactive and fun.
At Mass General, Scott Plotkin, MD, PhD, and Vijaya Ramesh, PhD, are using their respective expertise in clinical and fundamental science to investigate new treatments for neurofibromatosis and two related disorders.
Donor commitment allows rare disease research breakthrough, providing insights into Parkinson’s and other movement disorder diseases.
A study of smartphone use by a Mass General psychologist and Motorola found a few worrying trends, but also suggests that users still have time to regain “phone-life balance.”
The co-director of Mass General’s Eating Disorders Clinical and Research Program says recovery is possible for people struggling with anorexia, even after many years.
If transplant organs could be kept fresher for longer, they could help thousands more on wait-lists.